India's first COVID-19 vaccine candidate cleared for human trials
Published
Drug Controller General of India approves Bharat Biotech's Covaxin for clinical human trials which will start in July.
Full ArticlePublished
Drug Controller General of India approves Bharat Biotech's Covaxin for clinical human trials which will start in July.
Full ArticleNew Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to..
The first participants in South Africa's first clinical trial for a vaccine against COVID-19 will be vaccinated this..